Biomarkers for predicting rapid response to HCV treatment

Details for Australian Patent Application No. 2010317996 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Chiu, Shu-Hui; Zhu, Yonghong

Agent Spruson & Ferguson

Pub. Number AU-A-2010317996

PCT Pub. Number WO2011/058084

Priority 61/261,324 14.11.09 US

Filing date 11 November 2010

Wipo publication date 19 May 2011

International Classifications

G01N 33/576 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for hepatitis

C12Q 1/70 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving virus or bacteriophage

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

10 May 2012 PCT application entered the National Phase

  PCT publication WO2011/058084 Priority application(s): WO2011/058084

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010318017-Handover delay optimization

2010317995-Pharmaceutical composition comprising a GLP-1 agonist, an insulin, and methionine